Keyphrases
Treatment-resistant Depression
100%
Riluzole
100%
Acute Phase
42%
Response Rate
42%
Adverse Events
28%
Depression Treatment
28%
Relapse Rate
28%
Open-label Extension
28%
Depression Rating Scales
28%
Serious Adverse Events
14%
Suicide Attempt
14%
Antidepressant Treatment
14%
Antidepressants
14%
Non-responders
14%
Long-term Efficacy
14%
Treatment Trials
14%
Acute Treatment
14%
Shortness of Breath
14%
Vomiting
14%
Response Event
14%
Optimal Treatment Duration
14%
Medicine and Dentistry
Treatment Resistant Depression
100%
Riluzole
100%
Adverse Event
42%
Recurrence Risk
28%
Treatment of Depression
28%
Rating Scale
28%
Antidepressant
28%
Dyspnea
14%
Treatment Duration
14%
Suicide Attempt
14%
Pharmacology, Toxicology and Pharmaceutical Science
Treatment Resistant Depression
100%
Riluzole
100%
Adverse Event
42%
Antidepressant
28%
Recurrence Risk
28%
Dyspnea
14%
Suicide Attempt
14%
Neuroscience
Treatment-Resistant Depression
100%
Riluzole
100%
Antidepressant
28%
Treatment of Depression
28%
Dyspnea
14%
Suicide Attempt
14%